The expression of MMP9 has been related to a poorer prognosis in non-lymphoid tumors and in non-Hodgkin lymphoma [10], but lack of association has been reported in cHL, including a recent Brazilian study with 97 patients [11]–[13]. The gene discussed is MMP9; the disease is non-Hodgkin lymphoma.